Zydus Lifesciences Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate

Standalone


Total Qtr Revenue cr	7,721.20	6,975.90	6,232.20	6,728.60	6,608.50
Other Income Qtr Cr	134.20	111.40	109.00	154.90	80.60
Operating Revenues Qtr	7,587.00	6,864.50	6,123.20	6,573.70	6,527.90
Loading chart...
Operating Expenses Qtr	5,032.60	5,048.10	4,107.40	4,485.20	4,402.40
Operating Profit Qtr	2,554.40	1,816.40	2,015.80	2,088.50	2,125.50
EBITDA Qtr Cr	2,291.10	1,842.90	2,090.60	2,243.40	1,986.50
Depreciation Qtr	508.40	359.60	301.90	238.10	237.90
Net Profit Qtr	1,272.50	1,042.10	1,258.60	1,466.80	1,170.90
Basic EPS Qtr	12.65	10.36	12.51	14.58	11.64

Open Demat Account